Euclidean Capital LLC - 28 Apr 2021 Form 3 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: 10%+ Owner
Signature: /s/ Joseph Cosmai - Euclidean Capital LLC, By: Joseph Cosmai, Manager
Issuer symbol: PMVP
Transactions as of: 28 Apr 2021
Net transactions value: $0
Form type: 3
Filing time: 07 May 2021, 16:51:57 UTC
Next filing: 09 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PMVP	Common Stock						693,769	28 Apr 2021	See footnotes	F1, F6
holding	PMVP	Common Stock						2,601,637	28 Apr 2021	See footnotes	F2, F6
holding	PMVP	Common Stock						751,409	28 Apr 2021	See footnotes	F3, F6
holding	PMVP	Common Stock						132,601	28 Apr 2021	See footnotes	F4, F6
holding	PMVP	Common Stock						494,407	28 Apr 2021	See footnotes	F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Marilyn Simons and James Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean.
F2	The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean.
F3	The shares are held of record by Greenland FP LLC, which is managed by Euclidean.
F4	The shares are held of record by Greenland NFP LLC, which is managed by Euclidean.
F5	The shares are held of record by Symmetry Group Ltd ("Symmetry"). Mrs. Simons and Mr. Simons are on the board of directors of Symmetry's parent.
F6	Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein.